Therapies

How Effective Are Atypical Antipsychotics for Chronic Pain?

Olanzapine and quetiapine have gained attention as adjuncts in pain management regimens.

Effect of Group CBT on Preventing Weight Regain in Type 2 Diabetes

Over the long term, overweight and obese patients with type 2 diabetes often regain weight lost during weight loss programs.

ECT Associated Headaches Decreased With Preemptive Analgesia, Acetaminophen

ECT significantly reduced headache incidence and severity.

Clinical Hypnosis May Be Effective for Cancer Pain, IBS, Headaches

Results of brain imaging studies demonstrate that "hypnosis influences all of the cortical areas and neurophysiological processes that underlie pain and emotions."

The ADA Issues Guidelines for Psychosocial Care in Diabetes

The ADA released detailed guidelines for psychosocial assessments and care based on factors including age, type of diabetes, and family support system.

Issues With Clinical Trials That Impede New Pain Drug Development

The major issues of drug development are that pre-clinical animal efficacy studies do not accurately predict human efficacy, and clinical trials often inaccurately fail to show drug efficacy.

Predicting Placebo Response May Now be Possible

Connectivity in the right midfrontal gyrus may help predict placebo response. This finding has widespread implications in drug development.

Crystal Structure of Cannabinoid Receptor 1 Determined: Implications for Managing Pain

The crystal structure may provide inspiration for designing drugs that refine efficacy and avoid adverse events.

Vortioxetine Beats Escitalopram in Improving SSRI-Induced Sexual Dysfunction

Novel Narcolepsy Treatment Gets Orphan Drug Designation

Positive Results for Lemborexant in Insomnia Disorder Study

Abuse of Antidepressant for Weight Loss Leads to Seizures in Patient With Bulimia Nervosa

NDA Submitted for Novel Schizophrenia Treatment Lumateperone

Researchers Recommend Reclassification of Psilocybin

FDA to Review Vraylar sNDA for Treatment of Bipolar Depression

Psychiatric Adverse Effects of Disease-Modifying Therapies Assessed in MS Patients

FDA Issues Statement Addressing Safety Concerns Associated With Nuplazid

Treating Older Adult Bipolar Disorder: Newer Atypical Antipsychotics Compared

Guidelines for Managing Perimenopausal Depression Now Available

Esketamine Nasal Spray NDA Submitted to FDA for Treatment-Resistant Depression

FDA Rejects ADHD Drug NDA Citing Need for More Data

Lithium Efficacy, Safety Examined in Children, Adolescents With Bipolar Disorder

Psilocybin Study Gets Green Light From FDA for Treatment-Resistant Depression

TMS Device Cleared to Treat Obsessive Compulsive Disorder

Case: Hypertensive Crisis Following Use of Armodafinil + MAOI

Does Prenatal Tdap Vaccination Increase Autism Risk in Offspring?

ADHD Medications Compared for Efficacy, Tolerability in Children and Adults

Jornay PM Approved for the Treatment of ADHD